Lin Sun
9Patents
6h-index
13Co-inventors
56Inventor score
Filing activity: Apr 7, 2000 → Nov 29, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7858739B2 | Inhibitors of type 2 vascular endothelial growth factor receptors | Chemistry; Metallurgy | 62 | Active |
| US7847062B2 | Pharmacokinetic modulation and compositions for modified FN3 polypeptides | Chemistry; Metallurgy | 59 | Active |
| US8324362B2 | Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors | Chemistry; Metallurgy | 57 | Active |
| US8609613B2 | Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides | Chemistry; Metallurgy | 35 | Active |
| US9328157B2 | Inhibitors of type 2 vascular endothelial growth factor receptors | Chemistry; Metallurgy | 26 | Active |
| US9862758B2 | Inhibitors of type 2 vascular endothelial growth factor receptors | Chemistry; Metallurgy | 20 | Active |
| US10995131B2 | Libraries of modified fibronectin type III tenth domain-containing polypeptides | Chemistry; Metallurgy | 1 | Active |
| US6841722B1 | Nucleic acid encoding the arabidopsis SSE1 protein and a method of using it to modify plant storage reserves | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9493747B2 | Engineered transglutaminase barrel proteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.